Kathmere Capital Management LLC Takes Position in Solana Company $HSDT

Kathmere Capital Management LLC purchased a new position in shares of Solana Company (NASDAQ:HSDT) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 4,594,960 shares of the company’s stock, valued at approximately $7,949,000. Kathmere Capital Management LLC owned about 0.08% of Solana as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Price T Rowe Associates Inc. MD bought a new position in Solana during the fourth quarter valued at $46,000. Grant Private Wealth Management Inc purchased a new position in shares of Solana during the 4th quarter valued at $46,000. OMERS ADMINISTRATION Corp bought a new position in shares of Solana during the 4th quarter worth $88,000. Aristides Capital LLC bought a new position in shares of Solana during the 4th quarter worth $137,000. Finally, XTX Topco Ltd purchased a new stake in Solana in the 4th quarter worth about $140,000. Institutional investors own 18.63% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. B. Riley Financial started coverage on shares of Solana in a research report on Thursday, April 23rd. They set a “buy” rating and a $3.00 target price for the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Solana in a report on Tuesday, April 21st. Zacks Research raised shares of Solana to a “hold” rating in a report on Monday, April 27th. Finally, Maxim Group initiated coverage on Solana in a report on Monday, April 6th. They issued a “buy” rating and a $4.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $3.50.

Solana Stock Performance

Shares of Solana stock opened at $1.79 on Monday. Solana Company has a 12-month low of $1.19 and a 12-month high of $25.50. The company has a market cap of $104.52 million, a price-to-earnings ratio of -0.02 and a beta of 1.03. The company’s 50-day moving average price is $1.88 and its 200-day moving average price is $2.23.

Solana (NASDAQ:HSDT) last posted its earnings results on Friday, May 15th. The company reported ($1.30) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.96). Solana had a negative return on equity of 67.57% and a negative net margin of 1,427.15%.The firm had revenue of $3.62 million for the quarter, compared to the consensus estimate of $3.40 million. On average, sell-side analysts predict that Solana Company will post -0.09 earnings per share for the current year.

Solana Company Profile

Helius Medical Technologies, Inc (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non‐invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions.

The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics.